Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

40 results about "Microsporum lanosum" patented technology

Applications of Sarcaboside A in medicament against human fungus

The invention relates to applications of Sarcaboside A in preparing a medicament against human fungus, and belongs to the field of medicines. The Sarcaboside A plays a strong role in inhibiting trichophyton rubrum, microsporum lanosum or trichophyton tonsurans, therefore, the Sarcaboside A can serve as a compound with an anti-human fungus function, and is expected to be applied in preparing related medicaments. The applications of the Sarcaboside A in preparing the medicament against human fungus are disclosed for the first time. As a skeleton type of the Sarcaboside A belongs to a brand-new skeleton type, the Sarcaboside A has an unexpectedly strong human fungus inhibition activity, and the possibility of giving any inspiration by other compounds does not exist. The Sarcaboside A has significantly substantive characteristics, as well as obviously prominent progress in the prevention and treatment of the human fungus infection.
Owner:NANJING GUANGKANGXIE BIOLOGICAL MEDICAL TECH

Application of Kanshone C to preparing drug for resisting human body fungi

The invention relates to application of Kanshone C to preparing drug for resisting human body fungi and belongs to the medicine field. Kanshone C has a high inhibition effect on red trichophyton, microsporum lanosum or fungi imperficti, and therefore Kanshone C can serve as compounds resisting human body fungi, and it is hopeful that Kanshone C is applied to preparing relevant drugs. The application of Kanshone C to preparing drug for resisting human body fungi is disclosed for the first time, due to the fact that the skeleton type is a brand-new skeleton type, Kanshone C has unexpected inhibition activity on human body fungi, it is not possible that other compounds provide any revelation, Kanshone C has outstanding substantive features, and remarkable progress is made in human body fungus infection prevention and treatment.
Owner:ZIBO DINGLI PATENT INFORMATION CONSULTING CO LTD

Application of Houttuynoid C in anti-human fungal drugs

The invention relates to application of Houttuynoid C in preparing anti-human fungal drugs, belonging to the field of medicine. Houttuynoid C has strong effect of suppressing trichophyton rubrum, microsporum lanosum or trichophyton tonsurans; and therefore, Houttuynoid C can be taken as an anti-human fungal compound and is expected to be applied to preparing related drugs. The use of Houttuynoid C in preparing the anti-human fungal drugs involved in the invention is disclosed for the first time; as the framework type of Houttuynoid C is a brand new framework type and Houttuynoid C has an unexpectedly high inhibition activity for the human fungus without possibility of giving any implication by other compounds, Houttuynoid C has outstanding substantive features; and simultaneously, the application of Houttuynoid C for preventing and treating the human fungus apparently has obvious progress.
Owner:江苏鑫石器玄武岩纤维有限公司

Applications of compound in preparation anti human body fungus drugs

The invention relates to applications of Kadcoccitones A in preparation anti human body fungus drugs, and belongs to the field of medicine. Kadcoccitones A has strong functions of inhibiting trichophyton rubrum, microsporum lanosum or trichophyton tonsurans, so that Kadcoccitones A can be taken as a compound with the function of anti human body fungi, and is advantageously used for corresponding drugs.
Owner:深圳市茵诺圣生物科技有限公司

Application of Aphanamixoid A for preparing human fungal resistant medicine

The invention relates to application of Aphanamixoid A for preparing a human fungal resistant medicine, belonging to the field of medicines. Aphanamixoid A has strong effects on inhibiting trichophyton rubrum, microsporum lanosum or trichophyton tonsurans, therefore, Aphanamixoid A can be used as a human fungal resistant compound and is hopeful to be used for preparing related medicines. The application of Aphanamixoid A for preparing the human fungal resistant medicine is disclosed for the first time; because the skeleton type belongs to a brand new skeleton type and the human fungal inhibitory activity of Aphanamixoid A is strong unexpectedly, the possibility that other compounds give any inspiration does not exist; Aphanamixoid A has outstanding substantive characteristics; and simultaneously, Aphanamixoid A has obvious progress for preventing and treating human fungal infection.
Owner:何晓涛

Application of Chukrasone B in preparation of medicines for resisting human body fungi

The invention relates to an application of Chukrasone B in the preparation of medicines for resisting human body fungi, and belongs to the field of medicines. The Chukrasone B has a very strong inhibition effect on trichophyton rubrum, microsporum lanosum or trichophyton tonsurans, therefore, the Chukrasone B can serve as a compound capable of resisting human body fungi and is expected to be applied in the preparation of related medicines. The application of the Chukrasone B in the preparation of the medicines for resisting the human body fungi is disclosed by the invention for the first time. As the skeleton type of the Chukrasone B belongs to a bran-new skeleton type and the Chukrasone B has unexpected strong inhibitory activity on human body fungi, the possibility that other compounds provide revelation does not exist. The Chukrasone B has prominently substantial characteristics and meanwhile has remarkably progressive significance when being used for preventing and treating the human body fungi infection.
Owner:煌途医药(无锡)有限公司

Application of Chukrasone A for preparing antifungal drugs for human body

The invention relates to an application of Chukrasone A for preparing antifungal drugs for a human body. Chukrasone A has strong inhibition effect on trichophyton rubrum, microsporum lanosum or trichophyton tonsurans, so the Chukrasone A can be used as an anti human body fungal compound, and can be applied for preparing relative medicament. The application of Chukrasone A for preparing antifungal drugs for human body is firstly disclosed. Because a matrix type belongs to a new matrix type, and Chukrasone A has unexpectedly strong inhibition activity on human body fungus without possibility of any enlightenment given by other compounds, Chukrasone A has significantly substantive characteristics, and simultaneously has substantial progress for preventing human body infection fungus.
Owner:JIANGSU KEHUA MEDICAL INSTR TECH CO LTD

Application of Houttuynoid A in anti-human fungus drugs

The invention relates to an application of Houttuynoid A in preparing anti-human fungus drugs and belongs to the field of medicines. The Houttuynoid A is very powerful in effect of inhibiting trichophyton rubrum, microsporum lanosum or trichophyton tonsurans, and therefore, the Houttuynoid A can serve as an anti-human fungus compound, and is expected to be applied in preparing related drugs. The application of the Houttuynoid A in preparing the anti-human fungus drugs is disclosed for the first time. As the skeleton type of the Houttuynoid A is fire-new, and the inhibitory activity of the Houttuynoid A on human fungi is unexpectedly strong, the possibility that any enlightenments are given by other compounds does not exist. The Houttuynoid A is outstanding in substantive feature, and meanwhile, apparently makes a significant progress when being used for preventing and curing human fungus infections.
Owner:NANJING UNIV

Application of Friedolanostanes in preparation of antihuman fungal medicines

The invention relates to an application of Friedolanostanes in the preparation of antihuman fungal medicines, and belongs to the field of medicines. The Friedolanostanes have a very strong inhibition effect on Trichophyton rubrum, Microsporum lanosum or Trichophyton tonsurans, so the Friedolanostanes can be used as an antihuman fungal compound, and are hopeful to be applied to preparation of relevant medicines for the first time. The skeleton type of the Friedolanostanes is a brand new skeleton type, and the Friedolanostanes have high human fungus inhibition activity, have protruding practical characteristics, and have substantial progress in prevention and treatment of human fungus infection.
Owner:ZIBO DINGLI PATENT INFORMATION CONSULTING CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products